CVS Health Co. (NYSE:CVS – Get Free Report) gapped up prior to trading on Wednesday following a stronger than expected earnings report. The stock had previously closed at $55.00, but opened at $60.61. CVS Health shares last traded at $63.09, with a volume of 10,423,016 shares traded.
The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.18%. CVS Health’s dividend payout ratio is presently 67.51%.
Analyst Ratings Changes
View Our Latest Stock Analysis on CVS Health
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in CVS. State Street Corp boosted its stake in CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock worth $3,554,475,000 after buying an additional 1,989,066 shares during the period. Geode Capital Management LLC boosted its holdings in CVS Health by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator’s stock valued at $1,651,997,000 after acquiring an additional 461,569 shares during the period. Pzena Investment Management LLC boosted its stake in shares of CVS Health by 49.3% during the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock valued at $880,319,000 after purchasing an additional 6,475,271 shares during the period. Norges Bank bought a new stake in CVS Health during the 4th quarter valued at about $839,574,000. Finally, Charles Schwab Investment Management Inc. grew its stake in CVS Health by 5.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 12,918,949 shares of the pharmacy operator’s stock worth $579,932,000 after acquiring an additional 710,281 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.
CVS Health Trading Up 15.7 %
The firm has a market capitalization of $80.08 billion, a PE ratio of 16.15, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The stock’s 50-day moving average price is $50.61 and its 200 day moving average price is $55.92. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- 3 Best Fintech Stocks for a Portfolio Boost
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Best Aerospace Stocks Investing
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- Investing in Travel Stocks Benefits
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.